NovoMix QUIZ May 2023

Insulin Naive patients with type 1 diabetes, the recommended starting dose of NovoMix® 30 is 6 U at breakfast and 6 U at dinner (evening meal). However, it can also be initiated once daily with 12 U at dinner (evening meal).

• True

• False

NovoMix 30 can be used with caution in patients aged 6 to 9 year, however clinical data is available for this age group.

• True

• False

Limited data are available for NovoMix® 50 in children and adolescents below 18 years of age.

• True

• False

There are no restrictions on treatment with NovoMix® 50 during lactation.

• True

• False

Duration of action of NovoMix 50 is.

• 16 to 20 Hours

• 14 to 24 Hours

• 18 to 22 Hours

• None of these

The pharmacokinetics of NovoMix® 50 has not been investigated in paediatrics, elderly or patients with renal or hepatic impairment.

• True

• False

In patients with type 2 diabetes, a dose reduction of 20% is recommended for patients with an HbA1c more than 8% when a GLP-1 receptor agonist is added to NovoMix® 30.

• True

• False

In El Naggar et al, Switching from BHI 30 to BIAsp 30 how much HbA_1c reduction (%) was observed from baseline after six months?

• 1.6%

• 1.7%

• 1.8%

• 1.9%

In El Naggar et al, Switching from BHI 30 to BIAsp 30 after six months  …………..(%) less events of minor Hypoglycaemia were observed in BIAsp30 vs BHI?

• 61%

• 62%

• 63%

• 64%

The sub group analysis of A1cheive, El Naggar et al. has a cohort of:

• 6200 pts

• 6300 pts

• 6323 pts

• 6423 pts